{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:38:55Z","timestamp":1740123535922,"version":"3.37.3"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005874","name":"Universit\u00e0 degli Studi G. D'Annunzio Chieti Pescara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005874","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A multilayered computational workflow was designed to identify a druggable binding site on the surface of the E200K pathogenic mutant of the human prion protein, and to investigate the effect of the binding of small molecules in the inhibition of the early aggregation of this protein. At this purpose, we developed an efficient computational tool to scan the molecular interaction properties of a whole MD trajectory, thus leading to the characterization of plausible binding regions on the surface of PrP-E200K. These structural data were then employed to drive structure-based virtual screening and fragment-based approaches to the seeking of small molecular binders of the PrP-E200K. Six promising compounds were identified, and their binding stabilities were assessed by MD simulations. Therefore, analyses of the molecular electrostatic potential similarity between the bound complexes and unbound protein evidenced their potential activity as charged-based inhibitors of the PrP-E200K early aggregation.<\/jats:p>","DOI":"10.1007\/s10822-021-00393-7","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T07:07:21Z","timestamp":1623308841000},"page":"751-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study"],"prefix":"10.1007","volume":"35","author":[{"given":"Mariangela","family":"Agamennone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loriano","family":"Storchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5325-9452","authenticated-orcid":false,"given":"Roberto","family":"Paciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"393_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"key":"393_CR2","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. PNAS 95:13363\u201313383","journal-title":"PNAS"},{"key":"393_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/19336896.2019.1569451","volume":"13","author":"H Era\u00f1a","year":"2019","unstructured":"Era\u00f1a H (2019) The Prion 2018 round tables (II): A\u03b2, tau, \u03b1-synuclein\u2026 are they prions, prion-like proteins, or what? Prion 13:41\u201345","journal-title":"Prion"},{"key":"393_CR4","doi-asserted-by":"publisher","first-page":"a023507","DOI":"10.1101\/cshperspect.a023507","volume":"8","author":"JC Watts","year":"2018","unstructured":"Watts JC, Prusiner SB (2018) \u03b2-amyloid prions and the pathobiology of Alzheimer\u2019s disease. Cold Spring Harb Perspect Med 8:a023507","journal-title":"Cold Spring Harb Perspect Med"},{"key":"393_CR5","doi-asserted-by":"publisher","first-page":"E11029","DOI":"10.1073\/pnas.1717193114","volume":"114","author":"NR Johnson","year":"2017","unstructured":"Johnson NR, Condello C, Guan S, Oehler A, Becker J, Gavidia M, Carlson GA, Giles K, Prusiner SB (2017) Evidence for sortilin modulating regional accumulation of human \u03c4 prions in transgenic mice. PNAS 114:E11029\u2013E11036","journal-title":"PNAS"},{"key":"393_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1073\/pnas.1719369115","volume":"115","author":"AL Woerman","year":"2017","unstructured":"Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K, Mordes DA, Olson SH, Prusiner SB (2017) Familial Parkinson\u2019s point mutation abolishes multiple system atrophy prion replication. PNAS 115:409\u2013414","journal-title":"PNAS"},{"key":"393_CR7","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH, Glidden DV, Halliday GM, Middleton LT, Gentleman SM, Grinberg LT, Giles K (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. PNAS 112:E5308\u2013E5317","journal-title":"PNAS"},{"key":"393_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM (2006) Annu Rev Biochem 75:333\u2013366","journal-title":"Annu Rev Biochem"},{"key":"393_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1073\/pnas.97.1.145","volume":"97","author":"R Zahn","year":"2000","unstructured":"Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Garcia FL, Billeter M, Calzolai L, Wider G, W\u00fcthrich K (2000) NMR solution structure of the human prion protein. PNAS 97:145\u2013150","journal-title":"PNAS"},{"key":"393_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U","volume":"47","author":"ES Simon","year":"2000","unstructured":"Simon ES, Kahana E, Chapman J, Treves TA, Gabizon R, Rosenmann H, Zilber N, Korczyn AD (2000) Creutzfeldt\u2013Jakob disease profile in patients homozygous for the PRNP E200K mutation. Ann Neurol 47:257\u2013260","journal-title":"Ann Neurol"},{"key":"393_CR11","doi-asserted-by":"publisher","first-page":"43777","DOI":"10.1074\/jbc.M112.428235","volume":"287","author":"CF Machado","year":"2012","unstructured":"Machado CF, Beraldo FH, Santos TG, Bourgeon D, Landemberger MC, Roff\u00e9 M, Martins VR (2012) Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival. J Biol Chem 287:43777\u201343788","journal-title":"J Biol Chem"},{"key":"393_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/humu.21277","volume":"31","author":"K Nuytemans","year":"2010","unstructured":"Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31:763\u2013780","journal-title":"Hum Mutat"},{"key":"393_CR13","first-page":"240","volume":"1739","author":"M Goedert","year":"2005","unstructured":"Goedert M, Jakes R (2005) Mutations causing neurodegenerative tauopathies. Biochem Biophys Acta 1739:240\u2013250","journal-title":"Biochem Biophys Acta"},{"key":"393_CR14","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1046\/j.1471-4159.2001.00195.x","volume":"76","author":"H Rosenmann","year":"2001","unstructured":"Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z (2001) Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem 76:1654\u20131662","journal-title":"J Neurochem"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"33650","DOI":"10.1074\/jbc.C000483200","volume":"275","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, S\u00f6nnichsen FD (2000) Solution structure of the E200K variant of human prion protein implications for the mechanism of pathogenesis in familial prion diseases. J Biol Chem 275:33650\u201333654","journal-title":"J Biol Chem"},{"key":"393_CR16","doi-asserted-by":"publisher","first-page":"e38314","DOI":"10.1371\/journal.pone.0038314","volume":"7","author":"S Sorrentino","year":"2012","unstructured":"Sorrentino S, Bucciarelli T, Corsaro A, Tosatto A, Thellung S, Villa V, Schinin\u00e0 ME, Maras B, Galeno R, Scotti L, Creati F, Marrone A, Re N, Aceto A, Florio T, Mazzanti M (2012) Calcium binding promotes prion protein fragment 90\u2013231 conformational change toward a membrane destabilizing and cytotoxic structure. PLoS ONE 7:e38314","journal-title":"PLoS ONE"},{"key":"393_CR17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/prot.24836","volume":"83","author":"L Storchi","year":"2015","unstructured":"Storchi L, Paciotti R, Re N, Marrone A (2015) Investigation of the molecular similarity in closely related protein systems: the PrP case study. Proteins 83:1751\u20131765","journal-title":"Proteins"},{"key":"393_CR18","doi-asserted-by":"publisher","first-page":"e0168039","DOI":"10.1371\/journal.pone.0168039","volume":"11","author":"A Marrone","year":"2016","unstructured":"Marrone A, Re N, Storchi L (2016) The effects of Ca2+ concentration and E200K mutation on the aggregation propensity of PrPC: a computational study. PLoS ONE 11:e0168039","journal-title":"PLoS ONE"},{"key":"393_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/prot.25621","volume":"87","author":"R Paciotti","year":"2019","unstructured":"Paciotti R, Storchi L, Marrone A (2019) An insight of early PrP-E200K aggregation by combined molecular dynamics\/fragment molecular orbital approaches. Proteins 87:51\u201361","journal-title":"Proteins"},{"key":"393_CR20","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1039\/C8SC05627G","volume":"10","author":"JC Sang","year":"2019","unstructured":"Sang JC, Lee J, Dear AJ, De S, Meisl G, Thackray AM, Bujdoso R, Knowles TPJ, Klenerman D (2019) Direct observation of prion protein oligomer formation reveals an aggregation mechanism with multiple conformationally distinct species. Chem Sci 10:4588\u20134597","journal-title":"Chem Sci"},{"key":"393_CR21","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1039\/C9SC06501F","volume":"11","author":"AJ Dear","year":"2020","unstructured":"Dear AJ, Meisl G, \u0160ari\u0107 A, Michaels TCT, Kjaergaard M, Linse S, Knowles TPJ (2020) Identification of on- and off-pathway oligomers in amyloid fibril formation. Chem Sci 11:6236","journal-title":"Chem Sci"},{"key":"393_CR22","first-page":"946037","volume":"15","author":"SM Patil","year":"2015","unstructured":"Patil SM, Alexandrescu AT (2015) Charge-based inhibitors of amylin fibrillization and toxicity. J Diabetes Res 15:946037","journal-title":"J Diabetes Res"},{"key":"393_CR23","first-page":"144","volume":"12","author":"VL Sim","year":"2012","unstructured":"Sim VL (2012) Prion disease: chemotherapeutic strategies. Infect Disorders 12:144\u2013160","journal-title":"Infect Disorders"},{"key":"393_CR24","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1471-4159.1992.tb09437.x","volume":"59","author":"B Caughey","year":"1992","unstructured":"Caughey B, Race RE (1992) Potent inhibition of scrapie-associated PrP accumulation by Congo red. J Neurochem 59:768\u2013771","journal-title":"J Neurochem"},{"key":"393_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0005-2787(81)90069-1","volume":"655","author":"AM Woody","year":"1981","unstructured":"Woody AM, Reisbig RR, Woody RW (1981) Spectroscopic studies of Congo red binding to RNA polymerase. Biochim Biophys Acta 655:82\u201388","journal-title":"Biochim Biophys Acta"},{"key":"393_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1099\/0022-1317-73-3-661","volume":"73","author":"A Ladogana","year":"1992","unstructured":"Ladogana A, Casaccia P, Ingrosso L, Cibati M, Salvatore M, Xi YG, Masullo C, Pocchiari M (1992) Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol 73:661\u2013665","journal-title":"J Gen Virol"},{"key":"393_CR27","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1093\/emboj\/20.15.3957","volume":"20","author":"S Gilch","year":"2001","unstructured":"Gilch S, Winklhofer KF, Groschup MH, Nunziante M, Lucassen R, Spielhaupter C, Muranyi W, Riesner D, Tatzelt J, Schatzl HM (2001) Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J 20:3957\u20133966","journal-title":"EMBO J"},{"key":"393_CR28","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1128\/JVI.77.9.5499-5502.2003","volume":"77","author":"B Caughey","year":"2003","unstructured":"Caughey B, Raymond LD, Raymond GJ, Maxson L, Silveira J, Baron GS (2003) Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 77:5499\u20135502","journal-title":"J Virol"},{"key":"393_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/j.1471-4159.2007.05105.x","volume":"104","author":"I Hafner-Bratkovic","year":"2008","unstructured":"Hafner-Bratkovic I, Gaspersic J, Smid LM, Bresjanac M, Jerala R (2008) Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein\u2014a new mechanism for the inhibition of PrP(Sc) accumulation. J Neurochem 104:1553\u20131564","journal-title":"J Neurochem"},{"key":"393_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1099\/vir.0.83281-0","volume":"89","author":"C Riemer","year":"2008","unstructured":"Riemer C, Burwinkel M, Schwarz A, Gultner S, Mok SW, Heise I, Holtkamp N, Baier M (2008) Evaluation of drugs for treatment of prion infections of the central nervous system. J Gen Virol 89:594\u2013597","journal-title":"J Gen Virol"},{"key":"393_CR31","doi-asserted-by":"publisher","first-page":"e4440","DOI":"10.1371\/journal.pone.0004440","volume":"4","author":"R Hnasko","year":"2009","unstructured":"Hnasko R, Bruederle CE (2009) Inoculation of scrapie with the self-assembling RADA-peptide disrupts prion accumulation and extends hamster survival. PLoS ONE 4:e4440","journal-title":"PLoS ONE"},{"key":"393_CR32","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1128\/jvi.74.10.4894-4897.2000","volume":"74","author":"K Doh-Ura","year":"2000","unstructured":"Doh-Ura K, Iwaki T, Caughey B (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74:4894\u20134897","journal-title":"J Virol"},{"key":"393_CR33","doi-asserted-by":"publisher","first-page":"9836","DOI":"10.1073\/pnas.161274798","volume":"98","author":"C Korth","year":"2001","unstructured":"Korth C, May BC, Cohen FE, Prusiner SB (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. PNAS 98:9836\u20139841","journal-title":"PNAS"},{"key":"393_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/01.LAB.0000074919.08232.A2","volume":"83","author":"C Ryou","year":"2003","unstructured":"Ryou C, Legname G, Peretz D, Craig JC, Baldwin MA, Prusiner SB (2003) Differential inhibition of prion propagation by enantiomers of quinacrine. Lab Invest 83:837\u2013843","journal-title":"Lab Invest"},{"key":"393_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1128\/JVI.80.2.1044-1046.2006","volume":"80","author":"DA Kocisko","year":"2006","unstructured":"Kocisko DA, Caughey B (2006) Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivo. J Virol 80:1044\u20131046","journal-title":"J Virol"},{"key":"393_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens7010027","volume":"7","author":"ML Barreca","year":"2018","unstructured":"Barreca ML, Iraci N, Biggi S, Cecchetti V, Biasini E (2018) Pharmacological agents targeting the cellular prion protein. Pathogens 7:1\u201316","journal-title":"Pathogens"},{"key":"393_CR37","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1021\/acsmedchemlett.0c00528","volume":"11","author":"A Astolfi","year":"2020","unstructured":"Astolfi A, Spagnolli G, Biasini E, Barreca ML (2020) The compelling demand for an effective PrPC-directed therapy against prion diseases. ACS Med Chem Lett 11:2063\u20132067","journal-title":"ACS Med Chem Lett"},{"key":"393_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41551-019-0349-8","volume":"3","author":"K Yamaguchi","year":"2019","unstructured":"Yamaguchi K, Kamatari YO, Ono F, Shibata H, Fuse T, Elhelaly AE, Fukuoka M, Kimura T, Hosokawa-Muto J, Ishikawa T, Tobiume M, Takeuchi Y, Matsuyama Y, Ishibashi D, Nishida N, Kuwata K (2019) A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques. Nat Biomed Eng 3:206\u2013219","journal-title":"Nat Biomed Eng"},{"key":"393_CR39","doi-asserted-by":"publisher","first-page":"11921","DOI":"10.1073\/pnas.0702671104","volume":"104","author":"K Kuwata","year":"2007","unstructured":"Kuwata K, Nishida N, Matsumoto T, Kamatari YO, Hosokawa-Muto J, Kodama K, Nakamura HK, Kimura K, Kawasaki M, Takakura Y, Shirabe S, Takata J, Kataoka Y, Katamine S (2007) Hot spots in prion protein for pathogenic conversion. PNAS 104:11921\u201311926","journal-title":"PNAS"},{"key":"393_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41551-019-0367-6","volume":"3","author":"E Biasini","year":"2019","unstructured":"Biasini E (2019) A designer chaperone against prion diseases. Nat Biomed Eng 3:167\u2013168","journal-title":"Nat Biomed Eng"},{"key":"393_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ebiom.2016.06.010","volume":"9","author":"D Ishibashi","year":"2016","unstructured":"Ishibashi D, Nakagaki T, Ishikawa T, Atarashi R, Watanabe K, Cruz FA, Hamada T, Nishida N (2016) Structure-based drug discovery for prion disease using a novel binding simulation. EBioMedicine 9:238\u2013249","journal-title":"EBioMedicine"},{"key":"393_CR42","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) Fast parallel algorithms for short-range molecular dynamics. J Comput Chem 26:1701\u20131718","journal-title":"J Comput Chem"},{"key":"393_CR43","volume-title":"Intermolecular forces","author":"HJC Berendsen","year":"1981","unstructured":"Berendsen HJC, Postma JPM, Van Gunsteren WF, Hermans J (1981) Intermolecular forces. Reider Publishing Company, Dordrecht"},{"key":"393_CR44","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225\u201311236","journal-title":"J Am Chem Soc"},{"key":"393_CR45","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1021\/jp003919d","volume":"105","author":"GA Kaminski","year":"2001","unstructured":"Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WJ (2001) Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 105:6474\u20136487","journal-title":"J Phys Chem B"},{"key":"393_CR46","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen HJC, Postma JPM, Van Gunsteren WF, Di Nola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684\u20133690","journal-title":"J Chem Phys"},{"key":"393_CR47","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Frajie JCEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463\u20131472","journal-title":"J Comput Chem"},{"key":"393_CR48","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"TA Darden","year":"1993","unstructured":"Darden TA, York DM, Pedersen LG (1993) Particle mesh Ewald: An N\u22c5 log (N) method for Ewald sums in large systems. J Chem Phys 98:10089\u201310092","journal-title":"J Chem Phys"},{"key":"393_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AWS Da Silva","year":"2012","unstructured":"Da Silva AWS, Vranken WF (2012) ACPYPE - AnteChamber PYthon Parser interface. BMC Res Notes 5:367","journal-title":"BMC Res Notes"},{"key":"393_CR50","first-page":"100241","volume":"10","author":"A Bernardi","year":"2019","unstructured":"Bernardi A, Faller R, Reith D, Kirschner KN (2019) ACPYPE update for nonuniform 1\u20134 scale factors: conversion of the GLYCAM06 force field from AMBER to GROMACS. Software X 10:100241","journal-title":"Software X"},{"key":"393_CR51","doi-asserted-by":"publisher","first-page":"247260","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247260","journal-title":"J Mol Graph Model"},{"key":"393_CR52","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general AMBER force field. J Comput Chem 25:1157\u20131174","journal-title":"J Comput Chem"},{"key":"393_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graphics 14:33\u201338","journal-title":"J Mol Graphics"},{"key":"393_CR54","unstructured":"Schr\u00f6dinger LLC (2013) Maestro, Version 9.4. New York, NY, USA"},{"key":"393_CR55","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M","volume":"38","author":"X Daura","year":"1999","unstructured":"Daura X, Gademann K, Jaun B, Seebach D, Van Gunsteren WF, Mark AE (1999) Peptide folding: when simulation meets experiment. Angew Chem Int Ed 38:236\u2013240","journal-title":"Angew Chem Int Ed"},{"key":"393_CR56","unstructured":"Schr\u00f6dinger LLC (2010) MacroModel, version 9.8, New York, NY"},{"key":"393_CR57","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1021\/ja00172a038","volume":"112","author":"WC Still","year":"1990","unstructured":"Still WC, Tempczyk A, Hawley RC, Hendrickson T (1990) Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 112:6127\u20136129","journal-title":"J Am Chem Soc"},{"key":"393_CR58","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1021\/jp961992r","volume":"101","author":"M Di Qiu","year":"1997","unstructured":"Di Qiu M, Shenkin P, Hollinger F, Still W (1997) The GB\/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii. J Phys Chem A 101:3005\u20133014","journal-title":"J Phys Chem A"},{"key":"393_CR59","doi-asserted-by":"publisher","first-page":"33650","DOI":"10.1074\/jbc.C000483200","volume":"275","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Sonnichsen FD (2000) Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases. J Biol Chem 275:33650\u201333654","journal-title":"J Biol Chem"},{"key":"393_CR60","unstructured":"Schr\u00f6dinger LLC. Schr\u00f6dinger Suite 2017\u20133: MacroModel, Glide, SiteMap, LigPrep, Maestro; Schr\u00f6dinger LLC: New York, NY, USA, 2017"},{"key":"393_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","volume":"69","author":"T Halgren","year":"2007","unstructured":"Halgren T (2007) New method for fast and accurate binding-site identification and analysis. Chem Biol Drug Des 69:146\u2013148","journal-title":"Chem Biol Drug Des"},{"key":"393_CR62","unstructured":"Storchi L, SiteMap based binding sites search github repo: https:\/\/github.com\/lstorchi\/scantrj"},{"issue":"3","key":"393_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5194\/isprsannals-II-3-9-2014","volume":"2","author":"R Blomley","year":"2014","unstructured":"Blomley R, Weinmann M, Leitloff J, Jutzi B (2014) Shape distribution features for point cloud analysis-a geometric histogram approach on multiple scales. ISPRS Ann Photogram Remote Sens Spatial Inf Sci 2(3):9","journal-title":"ISPRS Ann Photogram Remote Sens Spatial Inf Sci"},{"key":"393_CR64","unstructured":"SiteMap User Manual Copyright \u00a9 2015 Schr\u00f6dinger, LLC"},{"key":"393_CR65","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/acs.accounts.5b00516","volume":"49","author":"A Stank","year":"2016","unstructured":"Stank A, Kokh DB, Fuller JC, Wade RC (2016) Protein binding pocket dynamics. Acc Chem Res 49:809\u2013815","journal-title":"Acc Chem Res"},{"key":"393_CR66","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"5","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2014Ligand discovery for everyone. J Chem Inf Model 5:2324\u20132337","journal-title":"J Chem Inf Model"},{"key":"393_CR67","first-page":"26","volume":"11","author":"MR Berthold","year":"2009","unstructured":"Berthold MR, Cebron N, Dill F, Gabriel TR, K\u00f6tter T, Meinl T, Ohl P, Thiel K, Wiswedel B (2009) KNIME - the Konstanz information miner: version 2.0 and beyond. Assoc Comput Mach 11:26\u201331","journal-title":"Assoc Comput Mach"},{"key":"393_CR68","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nbt855","volume":"21","author":"S Bach","year":"2003","unstructured":"Bach S, Talarek N, Andrieu T, Vierfond J, Mettey Y, Galons H, Dormont D, Meijer L, Cullin C, Blondel M (2003) Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol 21:1075\u20131081","journal-title":"Nat Biotechnol"},{"key":"393_CR69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.4155\/fmc-2017-0043","volume":"9","author":"J Bajorath","year":"2017","unstructured":"Bajorath J (2017) Computational scaffold hopping: cornerstone for the future of drug design? Future Med Chem 9:629\u2013631","journal-title":"Future Med Chem"},{"key":"393_CR70","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1021\/acs.accounts.9b00613","volume":"53","author":"A Kuzmanic","year":"2020","unstructured":"Kuzmanic A, Bowman GR, Juarez-Jimenez J, Michel J, Gervasio FL (2020) Investigating cryptic binding sites by molecular dynamics simulations. Acc Chem Res 53:654\u2013661","journal-title":"Acc Chem Res"},{"key":"393_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.str.2013.11.009","volume":"22","author":"PK Baral","year":"2014","unstructured":"Baral PK, Swayampakula M, Rout MK, Kav NN, Spyracopoulos L, Aguzzi A, James MN (2014) Structural basis of prion inhibition by phenothiazine compounds. Structure 22:291\u2013303","journal-title":"Structure"},{"key":"393_CR72","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1111\/j.1742-4658.2011.08304.x","volume":"278","author":"R Perez-Pineiro","year":"2011","unstructured":"Perez-Pineiro R, Bjorndahl TC, Berjanskii MV, Hau D, Li L, Huang A, Lee R, Gibbs E, Ladner C, Dong YW, Abera A, Cashman NR, Wishart DS (2011) The prion protein binds thiamine. FEBS J 278:4002\u20134014","journal-title":"FEBS J"},{"key":"393_CR73","doi-asserted-by":"publisher","first-page":"112197","DOI":"10.1016\/j.ejmech.2020.112197","volume":"192","author":"L Ma","year":"2020","unstructured":"Ma L, Yang C, Zheng J, Chen Y, Xiao Y, Huang K (2020) Non-polyphenolic natural inhibitors of amyloid aggregation. Eur J Med Chem 192:112197","journal-title":"Eur J Med Chem"},{"key":"393_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bcp.2017.04.004","volume":"139","author":"P Velander","year":"2017","unstructured":"Velander P, Wu L, Henderson F, Zhang S, Bevan DR, Xu B (2017) Natural product-based amyloid inhibitors. Biochem Pharmacol 139:40\u201355","journal-title":"Biochem Pharmacol"},{"key":"393_CR75","doi-asserted-by":"publisher","first-page":"10288","DOI":"10.1128\/JVI.77.19.10288-10294.2003","volume":"77","author":"DA Kocisko","year":"2003","unstructured":"Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B (2003) New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 77:10288\u201310294","journal-title":"J Virol"},{"key":"393_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67:27\u201337","journal-title":"Chem Biol Drug Des"},{"key":"393_CR77","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1021\/acs.molpharmaceut.8b00115","volume":"15","author":"LL Wen","year":"2018","unstructured":"Wen LL, Lyu M, Xiao HS, Lan HR, Zuo ZL, Yin ZN (2018) Protein aggregation and performance optimization based on microconformational changes of aromatic hydrophobic regions. Mol Pharm 15:2257\u20132267","journal-title":"Mol Pharm"},{"key":"393_CR78","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/19336896.2015.1115944","volume":"9","author":"D Huang","year":"2015","unstructured":"Huang D, Caflisch A (2015) The roles of the conserved tyrosine in the \u03b22\u2013\u03b12 loop of the prion protein. Prion 9:412\u2013419","journal-title":"Prion"},{"key":"393_CR79","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1021\/ja511568m","volume":"137","author":"D Huang","year":"2015","unstructured":"Huang D, Caflisch A (2015) Evolutionary conserved Tyr169 stabilizes the \u03b22\u2013\u03b12 loop of the prion protein. J Am Chem Soc 137:2948\u20132957","journal-title":"J Am Chem Soc"},{"key":"393_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41594-017-0018-0","volume":"25","author":"M Gallagher-Jones","year":"2018","unstructured":"Gallagher-Jones M, Glynn C, Boyer DR, Martynowycz MW, Hernandez E, Miao J, Zee C, Novikova IV, Goldschmidt L, McFarlane HT, Helguera GF, Evans JE, Sawaya MR, Cascio D, Eisenberg DS, Gonen T, Rodriguez JA (2018) Sub-\u00e5ngstr\u00f6m cryo-EM structure of a prion protofibril reveals a polar clasp. Nat Struct Mol Biol 25:131\u2013134","journal-title":"Nat Struct Mol Biol"},{"key":"393_CR81","doi-asserted-by":"publisher","first-page":"10069","DOI":"10.1073\/pnas.94.19.10069","volume":"94","author":"K Kaneko","year":"1997","unstructured":"Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE, Prusiner SB (1997) Evidence for protein Xbinding to a discontinuous epitope on the cellular prion protein duringscrapie prion propagation. PNAS 94:10069\u201310074","journal-title":"PNAS"},{"key":"393_CR82","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1021\/jm050610f","volume":"49","author":"TR Reddy","year":"2006","unstructured":"Reddy TR, Mutter R, Heal W, Guo K, Gillet VJ, Pratt S, Chen B (2006) Library design, synthesis, and screening: pyridine dicarbonitriles as potential prion disease therapeutics. J Med Chem 49:607\u2013615","journal-title":"J Med Chem"},{"key":"393_CR83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejmech.2007.02.018","volume":"43","author":"K Guo","year":"2008","unstructured":"Guo K, Mutter R, Heal W, Reddy TR, Cope H, Pratt S, Thompson MJ, Chen B (2008) Synthesis and evaluation of a focused library of pyridine dicarbonitriles against prion disease. Eur J Med Chem 43:93\u2013106","journal-title":"Eur J Med Chem"},{"key":"393_CR84","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1074\/jbc.M411638200","volume":"280","author":"EA Greenbaum","year":"2005","unstructured":"Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, Axelsen PH, Giasson BI (2005) The E46K mutation in alpha-synuclein increases amyloid fibril formation. J Biol Chem 280:7800\u20137807","journal-title":"J Biol Chem"},{"key":"393_CR85","doi-asserted-by":"publisher","first-page":"12680","DOI":"10.1021\/bi801427c","volume":"47","author":"JR Brender","year":"2008","unstructured":"Brender JR, Hartman K, Reid KR, Kennedy RT, Ramamoorthy A (2008) A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry 47:12680\u201312688","journal-title":"Biochemistry"},{"key":"393_CR86","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1021\/bi201857v","volume":"51","author":"EM Jones","year":"2012","unstructured":"Jones EM, Dubey M, Camp PJ, Vernon BC, Biernat J, Mandelkow E, Majewski J, Chi EY (2012) Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption. Biochemistry 51:2539\u20132550","journal-title":"Biochemistry"},{"key":"393_CR87","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/acschemneuro.7b00160","volume":"8","author":"M Zhang","year":"2017","unstructured":"Zhang M, Ren B, Liu Y, Liang G, Sun Y, Xu L, Zheng J (2017) Membrane interactions of hIAPP monomer and oligomer with lipid membranes by molecular dynamics simulations. ACS Chem Neurosci 8:1789\u20131800","journal-title":"ACS Chem Neurosci"},{"key":"393_CR88","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, Ouidja MO, Brodsky FM, Marasa J, Bagchi DP, Kotzbauer PT, Miller TM, Papy-Garcia D, Diamond MI (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. PNAS 110:E3138\u2013E3147","journal-title":"PNAS"},{"key":"393_CR89","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1021\/ja3115696","volume":"135","author":"FL Palhano","year":"2013","unstructured":"Palhano FL, Lee J, Grimster NP, Kelly JW (2013) Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J Am Chem Soc 135:7503\u20137510","journal-title":"J Am Chem Soc"},{"key":"393_CR90","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0140-6736(82)90652-3","volume":"2","author":"TW Furlow","year":"1982","unstructured":"Furlow TW, Whitley RJ, Wilmes FJ (1982) Repeated suppression of Creutzfeldt\u2013Jakob disease with vidarabine. Lancet 2:564\u2013565","journal-title":"Lancet"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-021-00393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-021-00393-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-021-00393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T20:08:35Z","timestamp":1675454915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-021-00393-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1007\/s10822-021-00393-7","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}